Health

Messi and three other PSG players test positive for COVID-19

Seven-time Ballon d’Or winner Lionel Messi is among four players in the Paris Saint-Germain squad to have tested positive for the coronavirus ahead of the team’s French Cup game on Monday night.

For the latest headlines, follow our Google News channel online or via the app.

PSG added that one staff member also had COVID-19 in a statement on Saturday night. None of them were named at that point, but in a further statement on the team’s medical news Sunday the club named Messi, left back Juan Bernat, backup goalie Sergio Rico and 19-year-old midfielder Nathan Bitumazala.

PSG is playing at third-tier Vannes.

Last year’s runner-up Monaco was in action later Sunday at second-tier Quevilly-Rouen in one of 13 games scheduled for the day as sides bid to reach the last 16.

Monaco said Saturday that seven players had COVID-19 but none showed any worrying signs and are isolating.

Expo 2020 Dubai continues to operate safely, responsibly amid COVID-19: Organizers

UAE’s COVID-19 cases rise to 2,556, with 908 recoveries, one death in last 24 hours

Health

‘Just in case’ use of antibiotics was rife during COVID-19, says UN health agency

Antibiotics saw “extensive overuse” globally among hospitalized COVID-19 patients during the pandemic without improving clinical outcomes, while also potentially exacerbating the already serious and growing threat of antimicrobial resistance, the UN World Health Organization (WHO) said on Friday.

Health

Teen alcohol and nicotine use in Europe is up, WHO urges preventive measures

Substance use is on the rise among teenagers in Europe, Central Asia and Canada and girls now match or even exceed boys when it comes to smoking and drinking, the World Health Organization (WHO) said in a new report on Thursday.

Health

Gender therapy review reveals devastating impacts on teens

A top Human Rights Council-appointed expert has welcomed the decision by all health authorities in the United Kingdom to halt the routine use of puberty-blockers offered to children as part of gender transition services, amid a sharp increase more widely in the number of teenage girls seeking such treatment and concerns that it might disrupt brain development.